Conventional papillary thyroid carcinoma: effects of cystic changes visible on ultrasonography on disease prognosis
- PMID: 25212970
- PMCID: PMC4176114
- DOI: 10.14366/usg.14028
Conventional papillary thyroid carcinoma: effects of cystic changes visible on ultrasonography on disease prognosis
Abstract
Purpose: To investigate the characteristics of papillary thyroid carcinoma (PTC) with cystic changes visible on ultrasonography (US).
Methods: This study included 553 PTCs in 553 patients between January 2003 and August 2004. One radiologist with 10 years of experience in thyroid imaging retrospectively reviewed the preoperative US images. Two different groups were formed according to two different reference points (group 1, 25%; group 2, 50%) of the cystic component. Patients between the groups were compared according to their clinicopathologic characteristics. Disease-free survival (DFS) was estimated. Cox's multivariate proportional hazards regression model was used to identify the effect of variable factors on the recurrence risk.
Results: Fifty-six patients (10.1%) were confirmed to have tumor recurrence within the follow-up period. Thirty-five patients had regional metastasis, one had distant metastasis, eight had multiple site metastases, and 12 had biochemical recurrence. PTC patients with a ≤ 50% or PTC patients with a ≤ 25% cystic component did not have a statistically significant longer DFS than those with a >50% (hazard ratio [HR], 1.118; 95% confidence interval [CI], 0.255 to 4.910; P=0.883) or those with a >25% cystic component (HR, 0.569; 95% CI, 0.164 to 1.976; P=0.375), respectively. Moreover, independent predictors of recurrence were pathologic size, male gender, and lymph node metastasis, not a >50% or >25% cystic component.
Conclusion: The proportion of the cystic component in PTCs did not affect DFS.
Keywords: Thyroid neoplasms; Thyroid nodule; Ultrasonography.
Conflict of interest statement
No potential conflict of interest relevant to this article was repoted.
Similar articles
-
Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma.Radiology. 2015 Nov;277(2):574-83. doi: 10.1148/radiol.2015142470. Epub 2015 May 8. Radiology. 2015. PMID: 25955580
-
Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?Thyroid. 2020 Jul;30(7):1008-1016. doi: 10.1089/thy.2019.0753. Epub 2020 Mar 17. Thyroid. 2020. PMID: 32059626
-
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29. Head Neck. 2015. PMID: 24821456
-
Cystic Lateral Lymph Node Metastases From Papillary Thyroid Cancer Patients.Laryngoscope. 2020 Dec;130(12):E976-E981. doi: 10.1002/lary.28631. Epub 2020 Apr 10. Laryngoscope. 2020. PMID: 32275332
-
Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.Cancer. 2016 Jan 15;122(2):198-206. doi: 10.1002/cncr.29689. Epub 2015 Oct 27. Cancer. 2016. PMID: 26506214
Cited by
-
BRAF and epithelial-mesenchymal transition in papillary thyroid carcinoma - challenging the roles of Snail and E-Cadherin?Am J Transl Res. 2016 Nov 15;8(11):5076-5086. eCollection 2016. Am J Transl Res. 2016. PMID: 27904709 Free PMC article.
-
Papillary Thyroid Carcinoma With Cystic Changes in a Patient With Prior History of Toxic Nodule.J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620942672. doi: 10.1177/2324709620942672. J Investig Med High Impact Case Rep. 2020. PMID: 32666838 Free PMC article.
-
Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas.Endocr Pathol. 2016 Sep;27(3):233-42. doi: 10.1007/s12022-016-9437-4. Endocr Pathol. 2016. PMID: 27256097
-
Hyperintense Thyroid Incidentaloma on Time of Flight Magnetic Resonance Angiography.Front Endocrinol (Lausanne). 2018 Jul 23;9:417. doi: 10.3389/fendo.2018.00417. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30083137 Free PMC article.
-
Utility of solid area diameter in management of cystic papillary thyroid carcinoma.Endocr Connect. 2024 May 3;13(6):e240040. doi: 10.1530/EC-24-0040. Print 2024 Jun 1. Endocr Connect. 2024. PMID: 38614121 Free PMC article.
References
-
- Henrichsen TL, Reading CC, Charboneau JW, Donovan DJ, Sebo TJ, Hay ID. Cystic change in thyroid carcinoma: prevalence and estimated volume in 360 carcinomas. J Clin Ultrasound. 2010;38:361–366. - PubMed
-
- Chan BK, Desser TS, McDougall IR, Weigel RJ, Jeffrey RB., Jr Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med. 2003;22:1083–1090. - PubMed
-
- Castro-Gomez L, Cordova-Ramirez S, Duarte-Torres R, Alonso de Ruiz P, Hurtado-Lopez LM. Cytologic criteria of cystic papillary carcinoma of the thyroid. Acta Cytol. 2003;47:590–594. - PubMed
-
- Lin JD, Hsuen C, Chen JY, Liou MJ, Chao TC. Cystic change in thyroid cancer. ANZ J Surg. 2007;77:450–454. - PubMed
-
- Abbas G, Heller KS, Khoynezhad A, Dubner S, Sznyter LA. The incidence of carcinoma in cytologically benign thyroid cysts. Surgery. 2001;130:1035–1038. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources